Epidermal Growth Factor Receptor as a Key Regulator of Immune Privilege
November 2022
in “
Journal of Investigative Dermatology
”
Studysummary This study implicates EGFR as a critical regulator of immune privilege and stem cell quiescence in hair follicles, suggesting a link between EGFR inhibition and inflammation-driven hair loss during cancer therapy. Our plain-language summary of this paper — not a Tressless recommendation.
The study highlights the role of the epidermal growth factor receptor (EGFR) as a crucial regulator of immune privilege in hair follicle stem cells. The research demonstrates that the EGFR/ERK signaling axis is essential for hair shaft emergence and skin barrier integrity. Inhibition of EGFR, often used in cancer therapy, can lead to skin inflammation and alopecia due to the loss of immune privilege in hair follicles. Using mouse models with hair follicle-specific EGFR deletion, the study observed a proliferative burst and subsequent loss of hair follicle stem cells, leading to alopecia. The research identified upregulation of antigen presentation machinery and proteasome pathways in these stem cells, suggesting a loss of immune privilege. The findings position EGFR as a master regulator of hair follicle stem cell quiescence and immune privilege, offering a new focus for developing therapies to manage inflammation-related tissue destruction.